deferoxamine has been researched along with dinoprostone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hiraishi, H; Ivey, KJ; Mutoh, H; Ota, S; Razandi, M; Sugimoto, T; Terano, A | 1 |
| Carbonell, MT; Mitjavila, MT; Muntané, J; Puig-Parellada, P; Sáiz, MP; Sánchez, J | 1 |
| Ciuffi, M; Franchi-Micheli, S; Mugnai, S; Tarlini, L; Zilletti, L | 1 |
| Hashimoto, K; Hisakawa, N; Matsumori, A; Nishiya, K; Tahara, K | 1 |
| Cui, X; Fujimoto, K; Imaizumi, T; Itaya, H; Ito, E; Matsumiya, T; Satoh, K; Tanji, K; Toki, T; Wakabayashi, K; Yoshida, H | 1 |
| Chavez, JC; LaManna, JC; Pichiule, P | 1 |
| Iida, M; Iino, K; Iwase, M; Sonoki, K; Yoshinari, M | 1 |
| Gasparetto, JC; Martins, CA; Otuki, MF; Pontarolo, R; Trindade, AC; Weffort-Santos, AM | 1 |
| Duan, X; Fan, Y; Gao, Y; Liu, C; Miao, Q; Pan, S; Wang, S; Xue, J; Xun, J; Zhang, Y | 1 |
10 other study(ies) available for deferoxamine and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Oxygen metabolites stimulate mucous glycoprotein secretion from cultured rat gastric mucous cells.
Topics: Animals; Catalase; Cell Survival; Cells, Cultured; Deferoxamine; Dinoprostone; Dose-Response Relationship, Drug; Free Radicals; Gastric Mucosa; Glycoproteins; Indomethacin; L-Lactate Dehydrogenase; Oxygen; Rats; Superoxide Dismutase; Time Factors; Xanthine Oxidase | 1991 |
Role of iron in carrageenan-induced granuloma: action of desferrioxamine and indometacin.
Topics: Animals; Carrageenan; Deferoxamine; Dinoprostone; Exudates and Transudates; Granuloma; Indomethacin; Iron; Leukocytes; Male; Rats; Rats, Inbred Strains | 1990 |
Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro.
Topics: Animals; Cerebral Cortex; Cyclooxygenase Inhibitors; Deferoxamine; Dinoprostone; Free Radical Scavengers; Hemoglobins; In Vitro Techniques; Indomethacin; Iron Chelating Agents; Lipid Peroxidation; Male; Penicillamine; Rats; Rats, Wistar; Vitamin E | 1996 |
Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts.
Topics: Aged; Arthritis, Rheumatoid; Cells, Cultured; Citric Acid; Deferoxamine; Depression, Chemical; Dinoprostone; Dose-Response Relationship, Drug; Female; Ferric Compounds; Fibroblasts; Humans; Interleukin-1; Iron Chelating Agents; Male; Middle Aged; Osteoarthritis, Knee; Recombinant Proteins; Synovial Membrane | 1998 |
Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line.
Topics: Binding Sites; Cell Line; Cyclooxygenase 2; Deferoxamine; Dinoprostone; Enzyme Stability; Genes, Reporter; Humans; Iron Chelating Agents; Isoenzymes; Macrophages; Membrane Proteins; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2001 |
Hypoxic regulation of angiopoietin-2 expression in endothelial cells.
Topics: Angiopoietin-2; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cells, Cultured; Cobalt; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Deferoxamine; Dinoprostone; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Iron Chelating Agents; Isoenzymes; Lactones; Membrane Proteins; Nuclear Proteins; Oligonucleotides, Antisense; Oxygen; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Recombinant Proteins; RNA, Messenger; Sulfones; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Combination treatment of vitamin C and desferrioxamine suppresses glomerular superoxide and prostaglandin E production in diabetic rats.
Topics: Animals; Ascorbic Acid; Deferoxamine; Depression, Chemical; Diabetes Mellitus, Experimental; Dinoprostone; Iron Chelating Agents; Kidney Glomerulus; Luminescent Measurements; Male; Rats; Rats, Sprague-Dawley; Superoxides | 2005 |
Malva sylvestris L. extract suppresses desferrioxamine-induced PGE₂ and PGD₂ release in differentiated U937 cells: the development and validation of an LC-MS/MS method for prostaglandin quantification.
Topics: Anti-Inflammatory Agents; Cell Survival; Chromatography, Liquid; Deferoxamine; Dinoprostone; Humans; Limit of Detection; Linear Models; Malva; Plant Extracts; Prostaglandin D2; Reproducibility of Results; Tandem Mass Spectrometry; U937 Cells | 2014 |
Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Deferoxamine; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Interleukin-1beta; Iron; Iron Chelating Agents; Lipopolysaccharides; Macrophages; Male; Mice; NF-kappa B; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Shock, Septic; Signal Transduction; Survival Analysis; Tumor Necrosis Factor-alpha | 2015 |